Bunge Global SA (BG) Stock Price, News, Analysis

Technical Score (1D)

BUY

News Sentiment

MIXED

Bunge Global’s latest filing revealed negative free‑cash flow and declining earnings, underscoring liquidity pressure that could force the company to raise equity capital. The prospect of new equity issuance raises dilution concerns, prompting the market to weigh the need for funding against protecting existing shareholders. Despite the cash conversion issue, BG’s valuation still offers upside if the company can improve cash generation in the near term. This liquidity risk is a key factor that could shape trading activity over the next 1–10 days. In contrast, BG’s year‑to‑date return has outpaced the broader basic‑materials sector, driven by higher commodity prices and operational efficiency gains. The strong performance suggests that commodity price gains have helped offset some of the cash flow weakness. Traders should monitor the upcoming earnings release for guidance on whether BG can convert revenue into cash and reduce reliance on external capital. Watch for any announcements regarding capital‑structure changes or debt refinancing that could mitigate dilution risk. Finally, keep an eye on commodity price forecasts, as they will continue to influence BG’s operational profitability and cash‑flow trajectory.

BG|Company Info

Sector

Consumer Defensive

Industry

Farm Products

Exchange

NYQ

Country

United States

Website

bunge.com

Symbol

Description

Bunge Limited is a global agribusiness and food company with a long history, tracing its roots back to 1818. The company's core operations are segmented into four key areas: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. Its Agribusiness division focuses on the procurement, storage, and distribution of agricultural commodities such as oilseeds and grains, serving as a critical link in the supply chain for animal feed, food processors, and biofuel producers. Bunge's Refined and Specialty Oils segment provides a diverse range of edible oils and fats to food manufacturers and retailers, including products for baked goods, snacks, and foodservice. Additionally, Bunge's Milling segment produces wheat flours, corn milling products, and other ingredients, while its Sugar and Bioenergy segment focuses on sugar, ethanol, and electricity generation from sugarcane.

BG|Earnings Snapshot

Earnings Summary

Bunge Limited is a global agribusiness and food company engaged in the procurement, storage, and distribution of agricultural commodities, as well as the production of refined oils, milling products, and sugar and bioenergy. Operating within the Consumer Defensive sector and the Farm Products industry, Bunge serves as a vital link in the global food and biofuel supply chains. The company's recent performance shows a mixed trend in earnings per share (EPS) against analyst estimates. In Q1 2025, Bunge reported an actual EPS of $1.81 against an estimate of $1.31, and in Q2 2025, actual EPS was $1.31 versus an estimate of $1.08. However, in Q4 2024, actual EPS was $2.13 against an estimate of $2.25, and in Q3 2025, actual EPS was $2.27 against an estimate of $1.97. Revenue figures are available for most quarters, with Q1 2026 revenue at $21.86 billion against an estimate of $23.37 billion, and Q3 2025 revenue at $22.16 billion with no estimate provided. Revenue in Q1 2025 was $11.64 billion, Q2 2025 was $12.77 billion, and Q4 2024 was $13.54 billion. The company has demonstrated an ability to beat EPS estimates in recent quarters, specifically Q1 2025 and Q2 2025, following a miss in Q4 2024 and a beat in Q3 2025. Recent news highlights Bunge Global's strategic realignment post-Viterra merger, focusing on expanding global origination and processing capabilities to capture synergies. The company reported Q1 adjusted EPS of $1.83, significantly beating analyst estimates, and raised its full-year adjusted EPS guidance. A new $3.00 billion share repurchase program was authorized, reflecting management's confidence. Analysts have responded positively, with upgrades from Zacks (Strong Buy) and Argus Research (BUY), and a maintained Overweight rating from Barclays. Investors should watch for the continued realization of synergies from the Viterra integration and management's commentary on navigating global trade dynamics and logistics costs in the upcoming quarters.

Read full report

EPS

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$1.93	-	-
Q1'26	$0.87	$1.83	+109.4%
Q3'25	$1.97	$2.27	+15.3%
Q2'25	$1.08	$1.31	+20.9%
Q1'25	$1.31	$1.81	+38.3%
Q4'24	$2.25	$2.13	-5.3%

Revenue

EstBeatMiss

Qtr	Est	Actual	+/−
Q2'26	$24.2B	-	-
Q1'26	$23.4B	$21.9B	-6.4%
Q3'25	-	$22.2B	-
Q2'25	-	$12.8B	-
Q1'25	-	$11.6B	-
Q4'24	-	$13.5B	-

Full Earnings BreakdownEstimates, actuals, guidance, and historical context

→

Market Data

BG Stock Snapshot

BG is currently trading at $126.46, giving Bunge Global SA a market cap of 24.54B and a P/E ratio of 35.9. Today's range spans $125.55–$130.00, with shares opening at $128.53 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 77/100 (BUY) with a news sentiment reading of 50/100.

Over the past year BG has traded between $71.60 and $134.87 - the current price is +76.6% off the 52-week low and -6.2% from the high.

Short interest data on large-cap Consumer Defensive names like BG (24.54B market cap) becomes relevant when the technical picture turns bullish - a BUY on 77/100 with neutral sentiment (50/100) is exactly the kind of setup that makes shorts nervous. Price at $126.46 (in the upper portion of its 52-week range in $71.60–$134.87). The current P/E ratio stands at 35.9. Short covering in a bullish technical phase can add a secondary momentum layer on top of genuine long-side conviction - a dynamic worth monitoring in the current setup.

What makes BG's BUY setup (77/100) particularly actionable at 24.54B in Consumer Defensive capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $126.46 (in the upper portion of its 52-week range in $71.60–$134.87), with sentiment running neutral at 50/100, the setup rewards conviction-sized positioning more than it does speculative small bets.

News Sentiment Analysis

Sentiment gathered from recent headlines

50/100

Strong NegativeNeutralStrong Positive

MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

Bunge Global (BG) reported negative free cash flow and declining earnings, raising concerns that the company may need equity financing to sustain operations. Despite solid sales, weak cash generation could erode shareholder value through dilution. The market is weighing the trade‑off between funding needs and protecting existing equity holders, while noting that BG’s valuation still offers upside potential if cash flow improves. Investors will focus on whether BG can convert revenue into cash and reduce reliance on external capital. The company’s liquidity position remains a key risk factor for the near term.

What did this article say?

Bunge Global (BG) has posted a year‑to‑date return that compares favorably with the broader basic materials sector. The company’s performance has been driven by higher commodity prices and improved operational efficiency. Traders should monitor upcoming earnings and commodity price forecasts for further guidance.

What did this article say?

Bunge (BG) is maintained on a Hold rating as its current valuation of over 14.5x P/E appears unattractive compared to historical averages. The assessment highlights fundamental headwinds that could constrain earnings growth. The high valuation relative to peers signals potential downside pressure if market sentiment shifts. Traders should consider how valuation dynamics and macro‑commodity trends may influence future price action.

What did this article say?

BG reported accelerating sales and consistent EPS beats, reinforcing its high growth trajectory. Analysts have raised target prices, citing robust commodity demand and favorable technical consolidation near key support levels. The company’s momentum suggests potential upside, but traders should monitor upcoming earnings and commodity price volatility.

What did this article say?

Argus Research has revised its price target for BG downwards to $126.00. This adjustment reflects a reassessment of the company's valuation within the current market environment. Investors should monitor future analyst commentary for further insights into the drivers behind this target modification.

What did this article say?

BG is identified as a key player in the AgriTech and Food Innovation sector, expected to capitalize on increasing market demand. The company's positioning suggests potential for portfolio enhancement for investors seeking exposure to this growth area. Analysts highlight BG as a notable stock within the industry.

What did this article say?

Bunge Global (BG) is drawing investor attention following significant recent share price appreciation, with a year-to-date return of 30.30% and a one-year total shareholder return of 58.91%. While recent 30-day performance has seen a slight pullback, the underlying momentum remains robust. The current valuation is being assessed against the company's fundamental performance.

What did this article say?

This analysis presents three specific concerns that suggest avoiding BG at this time. The article contrasts this negative outlook with a recommendation for an alternative stock, implying a shift in investor preference away from BG. Traders should note the specific reasons cited for caution regarding BG's prospects.

What did this article say?

This article compiles analyst ratings and price targets for Bunge Global (BG). It provides an overview of how Wall Street views the company's stock, reflecting current sentiment and expectations. Traders can use this information to understand the prevailing analyst consensus.

What did this article say?

Bunge (BG) shareholders approved an increased quarterly cash dividend of $0.72 per share at the 2026 Annual General Meeting. This represents a $0.02 per share increase from the previous year. The approval reflects management's confidence in the company's financial outlook and commitment to returning capital to shareholders.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles

What did this article say?

BG·Bunge Global SA

EPS

Revenue

BG Stock Snapshot

News Sentiment Analysis

Recent News Coverage

Discover More

News Sentiment Analysis

Recent News Coverage

Discover More